Blog

Filter By Year
COVID-19, Higher Education, and FERPA
20 January 2022 by CITI Program

At the beginning of March 2020, SARS-CoV-2 or COVID-19 changed everyday life in more ways than one. Higher education institutions faced unique challenges with the…

Recap of New OLAW Guidance and USDA Regulatory Updates
18 January 2022 by CITI Program

The Public Health Service (PHS), Office of Laboratory Animal Welfare (OLAW) recently published guidance on flexibilities for the conduct of semiannual animal facility inspections as…

What CITI Program is Reading – January 18, 2022
18 January 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

CITI Program’s January 2022 Media Playlist – Part 1
17 January 2022 by CITI Program

CITI Program’s media playlists highlight content curated by our staff and relevant to research, higher education, healthcare, technology, and more. Follow us on LinkedIn for…

NIH to Commit Two Million for Research on Bioethical Issues
4 January 2022 by CITI Program

The NIH has announced the availability of funds to provide grantees the opportunity to conduct research on bioethical issues and or develop projects that support…

FDA Creates Biosimilars Toolkit For Health Care Degree Programs
3 January 2022 by CITI Program

The FDA’s Center for Drug Evaluation and Research’s Office of Therapeutic Biologics and Biosimilars (OTBB) has created curriculum materials to help educators improve understanding about…

What CITI Program is Reading – January 11, 2022
11 January 2022 by CITI Program

“What CITI Program is Reading” is our weekly blog series which highlights news articles curated by our staff and relevant to research, higher education, healthcare,…

OSTP Releases Guidance on National Security for U.S. Government-Supported Research
7 January 2022 by CITI Program

On January 4, 2022, the White House Office of Science and Technology Policy (OSTP) released the report, “Guidance for Implementing National Security Presidential Memorandum 33…

FDA Releases Draft Guidance on Digital Health Technologies & Remote Clinical Investigations
6 January 2022 by CITI Program

In December of 2021, the FDA released a Draft Guidance document on “Digital Health Technologies for Remote Data Acquisition in Clinical Investigations.” Clinical trials may…

FDA Releases Draft Guidance on Real-World Evidence (RWE) in Clinical Trials
4 January 2022 by CITI Program

On December 9, 2021, the U.S. Food and Drug Administration (FDA) released draft guidance entitled “Considerations for the Use of Real-World Data and Real-World Evidence…